TERESA KOELLER: Open Payments
NPI 1457399917 · COVINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 31 payments from 8 companies in 2025. Trend: 2023 $348 · 2024 $598 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $144 |
| Braeburn Inc. | 12 | $136 |
| Indivior Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Alkermes, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: VRAYLAR, BRIXADI, SUBLOCADE, CAPLYTA, VIVITROL, HETLIOZ, Auvelity, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
